Sinovial® HL 32 – 1 ml
Hybrid 3,2% – 16 mg H-HA + 16 mg L-HA
For small joints

  • HYBRID HA
  • 1 ml
  • 16 mg high molecular weight HA + 16 mg low molecular weight HA
  • Biofermentative
  • Doping Free
  • Made in Italy
  • Compatible with PRP

Sinovial® HL 64 – 2 ml
Hybrid 3,2% – 32 mg H-HA + 32 mg LHA
For large joints

  • HYBRID HA
  • 2 ml
  • 32 mg high molecular weight HA + 32 mg low molecular weight HA
  • Biofermentative
  • Doping Free
  • Made in Italy
  • Compatible with PRP

Sinovial® HL 90 – 2 ml
Hybrid 4,5% – 45 mg H-HA + 45 mg LHA
For large joints

  • HYBRID HA
  • 2 ml
  • 45 mg high molecular weight HA + 45 mg low molecular weight HA
  • Biofermentative
  • Doping Free
  • Made in Italy
  • Compatible with PRP

WHAT IS IT?

Sinovial® HL is a HYBRID HYALURONIC ACID: it contains hybrid cooperative complexes of high and low molecular weight hyaluronic acid (HA) held together by hydrogen bonds.

Sinovial® HL is produced using NAHYCO® technology, a patented heat treatment that enables the combination of low and high molecular weight HA without using chemical reagents. It therefore reproduces the characteristics and properties of endogenous synovial fluid.

WHEN IS IT INDICATED?

Sinovial® HL is indicated in cases of pain or reduced mobility due to degenerative diseases (arthrosis), post-traumatic diseases and tendinopathy associated with joint disability.

WHAT IS IT USED FOR?

  • Pain relief and recovery of mobility in the joints and tendons
  • High HA concentration with low viscosity
  • Rheological properties similar to endogenous HA
  • High durability in the joints
  • Compatibility with PRP (platelet-rich plasma) infiltration therapy

HIGH CONCENTRATIONS
WITH LOW VISCOSITY

Sinovial® HL was developed by IBSA as a result of NAHYCO® Hybrid Technology, which is based on an innovative, patented thermal process that avoids the use of chemical reagents and leads to the formation of a series of weak hydrogen bonds between long (high molecular weight HA) and short (low molecular weight HA) chains of hyaluronic acid, forming stabilised hybrid complexes with optimal rheological characteristics and unique viscoelastic properties.

NAHYCO® Hybrid Technology allows to deliver high doses of hyaluronic acid (HA)
while maintaining low viscosity
. High concentrations of HA can thus be achieved without compromising the ease of extrusion.
In addition to this, the simultaneous presence of high and low molecular weight hyaluronic acid
means that Sinovial® HL has very similar characteristics to endogenous synovial fluid, mimicking its rheological properties.

PRODUCTS

IBSA specialises in research and development,
production and marketing of hyaluronic acid-based products

Made in Italy